Enrolling by invitationPHASE1, PHASE2NCT01852370
Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases
Studying Severe combined immunodeficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Paul Szabolcs
- Principal Investigator
- Paul Szabolcs, MDDivision of BMT and Cellular Therapy, Children's Hospital of Pittsburgh of UPMC
- Intervention
- CD3/CD19 negative allogeneic hematopoietic stem cells(biological)
- Enrollment
- 16 enrolled
- Eligibility
- 5-45 years · All sexes
- Timeline
- 2013 – 2027
Study locations (1)
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01852370 on ClinicalTrials.govOther trials for Severe combined immunodeficiency
Additional recruiting or active studies for the same condition.